• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Carlyle Credit Income Fund Schedules Fourth Quarter and Full Year 2025 Financial Results and Investor Conference Call

    10/20/25 4:05:00 PM ET
    $CCIF
    $CG
    Finance/Investors Services
    Finance
    Investment Managers
    Finance
    Get the next $CCIF alert in real time by email

    NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Carlyle Credit Income Fund ("we," "us," "our," "CCIF" or the "Fund") (NYSE:CCIF) announced today that it will release financial results after market close on Tuesday, November 18, 2025, for its fourth quarter and full year 2025. CCIF will host a conference call at 10:00 a.m. EST on Wednesday, November 19, 2025, to discuss the results.

    The conference call will be available via public webcast via a link on Carlyle Credit Income Fund's website at www.carlylecreditincomefund.com and will also be available on the website soon after the call's completion.

    About Carlyle Credit Income Fund

    Carlyle Credit Income Fund (NYSE:CCIF) is an externally managed closed-end fund focused on investing in primarily equity and junior debt tranches of collateralized loan obligations ("CLOs"). The CLOs are collateralized by a portfolio consisting primarily of U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors. CCIF is externally managed by Carlyle Global Credit Investment Management L.L.C. ("CGCIM"), an SEC-registered investment adviser and wholly owned subsidiary of Carlyle. CCIF draws upon the significant scale and resources of Carlyle as one of the world's largest CLO managers.

    Web: www.carlylecreditincomefund.com

    About Carlyle   

    Carlyle (NASDAQ:CG) is a global investment firm with deep industry expertise that deploys private capital across three business segments: Global Private Equity, Global Credit and Carlyle AlpInvest. With $465 billion of assets under management as of June 30, 2025, Carlyle's purpose is to invest wisely and create value on behalf of its investors, portfolio companies and the communities in which we live and invest. Carlyle employs more than 2,300 people in 27 offices across four continents. Further information is available at www.carlyle.com. Follow Carlyle on X @OneCarlyle and on LinkedIn at The Carlyle Group.

    Contacts:

    Investors:Media:
    Joseph CastillaKristen Ashton
    +1 (866) 277-8243

    [email protected]
    +1 (212) 813-4763

    [email protected]
      


    Get the next $CCIF alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CCIF
    $CG

    CompanyDatePrice TargetRatingAnalyst
    The Carlyle Group Inc.
    $CG
    12/11/2025$74.00Buy
    UBS
    The Carlyle Group Inc.
    $CG
    10/3/2025$74.00Outperform
    BMO Capital Markets
    The Carlyle Group Inc.
    $CG
    7/10/2025$65.00Neutral → Buy
    Citigroup
    The Carlyle Group Inc.
    $CG
    5/14/2025$56.00Hold → Buy
    TD Cowen
    The Carlyle Group Inc.
    $CG
    3/19/2025Outperform → Perform
    Oppenheimer
    The Carlyle Group Inc.
    $CG
    1/3/2025$60.00Peer Perform → Outperform
    Wolfe Research
    Carlyle Credit Income Fund Shares of Beneficial Interest
    $CCIF
    12/9/2024$8.00Perform
    Oppenheimer
    The Carlyle Group Inc.
    $CG
    9/12/2024$42.00Equal Weight
    Wells Fargo
    More analyst ratings

    $CCIF
    $CG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Carlyle Group Inc. disposed of 6,815,617 units of Class B Common Stock, sold $554,953,657 worth of shares (19,136,333 units at $29.00), disposed of 1,549,243 shares and converted options into 6,815,617 shares (SEC Form 4)

    4 - Carlyle Group Inc. (0001527166) (Reporting)

    12/22/25 4:30:22 PM ET
    $CG
    Investment Managers
    Finance

    Chief Operating Officer Lobue Lindsay was granted 183,655 shares, increasing direct ownership by 39% to 660,500 units (SEC Form 4)

    4 - Carlyle Group Inc. (0001527166) (Issuer)

    12/19/25 7:48:27 PM ET
    $CG
    Investment Managers
    Finance

    Chief Financial Officer Redett John C. was granted 550,965 shares, increasing direct ownership by 50% to 1,651,081 units (SEC Form 4)

    4 - Carlyle Group Inc. (0001527166) (Issuer)

    12/19/25 7:48:18 PM ET
    $CG
    Investment Managers
    Finance

    $CCIF
    $CG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Resonetics® Expands Bioelectronics Implant Offering with Acquisition of Manufacturing Assets and Process IP from Med-Ally

    NASHUA, N.H., Jan. 6, 2026 /PRNewswire/ -- Resonetics® announced today that it has acquired the manufacturing assets, process know-how, and intellectual property related to implantable and external pulse generators (IPG/EPG) and leads manufacturing and assembly from Med-Ally, a medical technology design and development company focused on the neuromodulation market and based in Charleston, South Carolina. The acquisition strengthens Resonetics' Medical Power business by combining its comprehensive implantable battery technologies with advanced pulse generator manufacturing proc

    1/6/26 8:00:00 AM ET
    $CG
    Investment Managers
    Finance

    Abingworth Announces Leadership Transition and Appointments

    Kurt von Emster transitions role of Head of Abingworth Life Sciences to Dr. Bali Muralidhar Travis Wilson joins as Managing Director across Abingworth and Carlyle, focusing on clinical co-development and life sciences buyout opportunities Kurt remains a Managing Partner of Abingworth focusing on clinical co-development investments and supporting venture investments while advancing Abingworth's strategic vision for growth January 5, 2026 – Abingworth, a leading transatlantic life sciences investment firm and part of global investment firm Carlyle (NASDAQ:CG), today announced several leadership changes. Kurt von Emster, Managing Partner and Head of Abingworth Life Sciences, is transitioning

    1/5/26 4:00:00 AM ET
    $CG
    Investment Managers
    Finance

    Vantage Group Holdings to be acquired by Howard Hughes Holdings

    Vantage's Diversified Specialty Insurance Platform Delivers Lower Risk and Superior Return Potential HHH to Host a Conference Call and Presentation on Thursday, December 18 at 8:30 a.m. ET, With an X Spaces Session to Follow HAMILTON, Bermuda, Dec. 18, 2025 /PRNewswire/ -- Vantage Group Holdings Ltd. ("Vantage"), a privately held leading specialty insurance and reinsurance company backed by Carlyle and Hellman & Friedman today announced that it has entered into a definitive agreement for Howard Hughes Holdings Inc. (NYSE:HHH) ("Howard Hughes," "HHH," or the "Company") to acquire 100% of Vantage for $2.1 billion in cash or approximately 1.5x year-end 2025 book value. The transaction is expect

    12/18/25 6:12:00 AM ET
    $CG
    $HHH
    Investment Managers
    Finance
    Real Estate Investment Trusts
    Real Estate

    $CCIF
    $CG
    SEC Filings

    View All

    The Carlyle Group Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Carlyle Group Inc. (0001527166) (Filer)

    12/5/25 4:10:33 PM ET
    $CG
    Investment Managers
    Finance

    Carlyle Credit Income Fund Shares of Beneficial Interest filed SEC Form 8-K: Other Events

    8-K - Carlyle Credit Income Fund (0001517767) (Filer)

    11/14/25 4:03:59 PM ET
    $CCIF
    Finance/Investors Services
    Finance

    SEC Form 497AD filed by Carlyle Credit Income Fund Shares of Beneficial Interest

    497AD - Carlyle Credit Income Fund (0001517767) (Filer)

    11/14/25 4:03:28 PM ET
    $CCIF
    Finance/Investors Services
    Finance

    $CCIF
    $CG
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Basmadjian Lauren Michelle bought $49,994 worth of shares (7,898 units at $6.33), increasing direct ownership by 58% to 21,448 units (SEC Form 4)

    4 - Carlyle Credit Income Fund (0001517767) (Issuer)

    7/1/25 5:06:23 PM ET
    $CCIF
    Finance/Investors Services
    Finance

    Director Mccabe Joan Y bought $99,995 worth of shares (15,822 units at $6.32), increasing direct ownership by 52% to 46,180 units (SEC Form 4)

    4 - Carlyle Credit Income Fund (0001517767) (Issuer)

    6/30/25 4:03:14 PM ET
    $CCIF
    Finance/Investors Services
    Finance

    President and PEO Mehta Nishil bought $100,233 worth of shares (16,650 units at $6.02), increasing direct ownership by 103% to 32,754 units (SEC Form 4)

    4 - Carlyle Credit Income Fund (0001517767) (Issuer)

    6/25/25 4:17:36 PM ET
    $CCIF
    Finance/Investors Services
    Finance

    $CCIF
    $CG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Subject)

    11/15/24 5:22:29 PM ET
    $CG
    Investment Managers
    Finance

    Amendment: SEC Form SC 13G/A filed by Carlyle Credit Income Fund Shares of Beneficial Interest

    SC 13G/A - Carlyle Credit Income Fund (0001517767) (Subject)

    11/14/24 4:09:42 PM ET
    $CCIF
    Finance/Investors Services
    Finance

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)

    10/21/24 4:31:27 PM ET
    $CG
    Investment Managers
    Finance

    $CCIF
    $CG
    Leadership Updates

    Live Leadership Updates

    View All

    Abingworth Announces Leadership Transition and Appointments

    Kurt von Emster transitions role of Head of Abingworth Life Sciences to Dr. Bali Muralidhar Travis Wilson joins as Managing Director across Abingworth and Carlyle, focusing on clinical co-development and life sciences buyout opportunities Kurt remains a Managing Partner of Abingworth focusing on clinical co-development investments and supporting venture investments while advancing Abingworth's strategic vision for growth January 5, 2026 – Abingworth, a leading transatlantic life sciences investment firm and part of global investment firm Carlyle (NASDAQ:CG), today announced several leadership changes. Kurt von Emster, Managing Partner and Head of Abingworth Life Sciences, is transitioning

    1/5/26 4:00:00 AM ET
    $CG
    Investment Managers
    Finance

    Acentra Health Appoints President and Chief Operations Officer Meghan Harris to Its Board of Directors

    MCLEAN, Va., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions company dedicated to accelerating better health outcomes for government and commercial clients and the populations they serve, today announced the appointment of Meghan Harris, President and Chief Operations Officer (COO), to its board of directors. Harris brings over two decades of healthcare quality improvement, strategic operations, and client-focused innovation to the board. As President and COO, she oversees all public and commercial operations, solution development and quality, and contract implementations. "Meghan's appointment to the board reflects the significant impact of her strate

    12/17/25 9:33:00 AM ET
    $CG
    Investment Managers
    Finance

    Acentra Health Names Patty Obermaier as Chief Growth Officer

    MCLEAN, Va., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions company dedicated to accelerating better health outcomes for government and commercial clients and the populations they serve, today announced that former Microsoft executive Patty Obermaier has joined the company as Executive Vice President, Chief Growth Officer (CGO). In this role, Obermaier will lead the company's business development, marketing, and product management functions to bring innovative solutions to the healthcare industry's most pressing challenges. A distinguished executive with more than three decades of experience driving innovation, growth, and operational excellence across

    12/11/25 9:32:00 AM ET
    $ASGN
    $CG
    Professional Services
    Consumer Discretionary
    Investment Managers
    Finance

    $CCIF
    $CG
    Financials

    Live finance-specific insights

    View All

    Vantage Group Holdings to be acquired by Howard Hughes Holdings

    Vantage's Diversified Specialty Insurance Platform Delivers Lower Risk and Superior Return Potential HHH to Host a Conference Call and Presentation on Thursday, December 18 at 8:30 a.m. ET, With an X Spaces Session to Follow HAMILTON, Bermuda, Dec. 18, 2025 /PRNewswire/ -- Vantage Group Holdings Ltd. ("Vantage"), a privately held leading specialty insurance and reinsurance company backed by Carlyle and Hellman & Friedman today announced that it has entered into a definitive agreement for Howard Hughes Holdings Inc. (NYSE:HHH) ("Howard Hughes," "HHH," or the "Company") to acquire 100% of Vantage for $2.1 billion in cash or approximately 1.5x year-end 2025 book value. The transaction is expect

    12/18/25 6:12:00 AM ET
    $CG
    $HHH
    Investment Managers
    Finance
    Real Estate Investment Trusts
    Real Estate

    Carlyle Credit Income Fund Announces Fourth Quarter and Full Year 2025 Financial Results and Declares Monthly Common and Preferred Dividends

    NEW YORK, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Carlyle Credit Income Fund ("we," "us," "our," "CCIF" or the "Fund") (NYSE:CCIF) today announced its financial results for its fourth quarter and full year ended September 30, 2025. The full detailed presentation of the Fund's fourth quarter and full year ended September 30, 2025, financial results can be viewed on the Fund's website (carlylecreditincomefund.com/investor-dashboard). "Our fourth-quarter results reflect continued focus on positioning CCIF for long-term success," said Nishil Mehta, CCIF's Principal Executive Officer and President. "In the quarter we completed five resets and two refinancings in the underlying portfolio to extend re

    11/18/25 5:53:22 PM ET
    $CCIF
    Finance/Investors Services
    Finance

    ARMADA Acquires Poseidon Industrial LLC, Expanding Its Solutions Offering to the U.S. Navy and Defense Support Capabilities

    Strategic acquisition strengthens ARMADA's Fleet and enhances its ability to deliver preservation, modernization, and technical services across naval programs. ARMADA Parent Inc., a leading solutions provider for outsourced U.S. Navy ship repair and construction, today announced the acquisition of Poseidon Industrial LLC ("Poseidon"). Poseidon is a Virginia based company supporting the U.S. Navy and defense industry with mechanical, electrical, and systems integration services for modernization and repair projects. ARMADA, which is majority owned by Carlyle (NASDAQ:CG) and Stellex Capital Management, delivers integrated mission-critical solutions across its national footprint of operating

    11/12/25 1:00:00 PM ET
    $CG
    Investment Managers
    Finance

    $CCIF
    $CG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    UBS resumed coverage on Carlyle Group with a new price target

    UBS resumed coverage of Carlyle Group with a rating of Buy and set a new price target of $74.00

    12/11/25 9:06:22 AM ET
    $CG
    Investment Managers
    Finance

    BMO Capital Markets initiated coverage on Carlyle Group with a new price target

    BMO Capital Markets initiated coverage of Carlyle Group with a rating of Outperform and set a new price target of $74.00

    10/3/25 8:37:30 AM ET
    $CG
    Investment Managers
    Finance

    Carlyle Group upgraded by Citigroup with a new price target

    Citigroup upgraded Carlyle Group from Neutral to Buy and set a new price target of $65.00

    7/10/25 8:23:02 AM ET
    $CG
    Investment Managers
    Finance